# Comparing The PK Of Aramchol Meglumine Granules To Aramchol Free Acid Tablets

> **NCT06502561** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Galmed Pharmaceuticals Ltd** · enrollment: 16 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Aramchol meglumine
- **DRUG:** Aramchol free acid

## Key facts

- **NCT ID:** NCT06502561
- **Lead sponsor:** Galmed Pharmaceuticals Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-02-15
- **Primary completion:** 2025-06-15
- **Final completion:** 2025-12
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2025-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06502561

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06502561, "Comparing The PK Of Aramchol Meglumine Granules To Aramchol Free Acid Tablets". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06502561. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*